IOVS Biophysical Journal
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maihöfner, C.
Right arrow Articles by Brune, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maihöfner, C.
Right arrow Articles by Brune, K.
(Investigative Ophthalmology and Visual Science. 2001;42:2616-2624.)
© 2001 by The Association for Research in Vision and Ophthalmology, Inc.

Expression of Cyclooxygenase-1 and -2 in Normal and Glaucomatous Human Eyes

Christian Maihöfner1,2, Ursula Schlötzer-Schrehardt2,3, Hans Gühring1, Hanns Ulrich Zeilhofer1, Gottfried O. H. Naumann3, Andreas Pahl1, Christian Mardin3, Ernst R. Tamm4 and Kay Brune1

1 From the Departments of Experimental and Clinical Pharmacology and Toxicology, 3 Ophthalmology, and 4 Anatomy II, University of Erlangen-Nürnberg, Germany.

PURPOSE. Primary open-angle glaucoma (POAG) is the predominant form of chronic glaucoma, but the underlying pathologic mechanisms are largely unknown. Because prostaglandins (PGs) have been introduced into POAG treatment with remarkable success, this study was undertaken to investigate whether a change in the expression of the PG-synthesizing enzymes cyclooxygenase (COX)-1 and -2 might be involved in the pathogenesis of POAG.

METHODS. Expression of COX-1 and -2 was assessed by confocal laser microscopy, immunohistochemistry, Western blot analysis, and real-time RT-PCR in human eyes with different forms of glaucoma (primary open-angle, angle-closure, congenital juvenile, and steroid-induced), as well as in age-matched control eyes. Additionally, PGE2 was measured in aqueous humor by means of an enzyme-linked immunoassay as a product of COX activity.

RESULTS. In normal eyes, ocular COX-1 and -2 expression were largely confined to the nonpigmented secretory epithelium of the ciliary body. By immunohistochemistry and real-time RT-PCR, COX-2 expression was completely lost in the nonpigmented secretory epithelium of the ciliary body of eyes with end-stage POAG, whereas COX-1 expression was unchanged. By immunohistochemistry, in the ciliary bodies of eyes in five patients with diagnosis of early POAG, eyes in two had complete loss of COX-2 expression and in three showed only a few remaining scattered COX-2–expressing cells. COX-2 expression in the ciliary body was also lost in patients with steroid-induced glaucoma and was reduced in patients receiving topical steroid treatment. Eyes of patients with either congenital juvenile or angle-closure glaucoma showed COX-2 expression indistinguishable from control eyes. Aqueous humor of eyes with POAG contained significantly less PGE2 than control eyes.

CONCLUSIONS. Both cyclooxygenase isoforms are constitutively expressed in the normal human eye. Specific loss of COX-2 expression in the nonpigmented secretory epithelium of the ciliary body appears to be linked to the occurrence of POAG and steroid-induced glaucoma.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
S. Rosch, R. Ramer, K. Brune, and B. Hinz
R(+)-Methanandamide and Other Cannabinoids Induce the Expression of Cyclooxygenase-2 and Matrix Metalloproteinases in Human Nonpigmented Ciliary Epithelial Cells
J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1219 - 1228.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
V. Mollace, C. Muscoli, E. Masini, S. Cuzzocrea, and D. Salvemini
Modulation of Prostaglandin Biosynthesis by Nitric Oxide and Nitric Oxide Donors
Pharmacol. Rev., June 1, 2005; 57(2): 217 - 252.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
T. C. Chen, D. S. Walton, and L. S. Bhatia
Aphakic Glaucoma After Congenital Cataract Surgery
Arch Ophthalmol, December 1, 2004; 122(12): 1819 - 1825.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
R. S. Sellers, L. Silverman, and K. N. M. Khan
Cyclooxygenase-2 Expression in the Cornea of Dogs with Keratitis
Vet. Pathol., March 1, 2004; 41(2): 116 - 121.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. Maihofner, M. P. Charalambous, U. Bhambra, T. Lightfoot, G. Geisslinger, N. J. Gooderham, and The Colorectal Cancer Group
Expression of cyclooxygenase-2 parallels expression of interleukin-1beta, interleukin-6 and NF-kappaB in human colorectal cancer
Carcinogenesis, April 1, 2003; 24(4): 665 - 671.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. L. Wilkinson-Berka, N. S. Alousis, D. J. Kelly, and R. E. Gilbert
COX-2 Inhibition and Retinal Angiogenesis in a Mouse Model of Retinopathy of Prematurity
Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 974 - 979.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
U. Schlotzer-Schrehardt, M. Zenkel, and R. M. Nusing
Expression and Localization of FP and EP Prostanoid Receptor Subtypes in Human Ocular Tissues
Invest. Ophthalmol. Vis. Sci., May 1, 2002; 43(5): 1475 - 1487.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. Hinz and K. Brune
Cyclooxygenase-2---10 Years Later
J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 367 - 375.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Association for Research in Vision and Ophthalmology